Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection

Immunity

Volumn 16, Issue 4, 2002, Pages 583-594

  Baron, Jody L ^a,b,c   Gardiner, Leon ^b   Nishimura, Stephen ^c   Shinkai, Kanade ^b,c   Locksley, Richard ^a,b,c   Ganem, Don ^a,b,c  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b Depts Med Microbiol and Immunol   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; ANTIGEN; CD1 ANTIGEN; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ACUTE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVATION; CELL ASSAY; CELL FUNCTION; CELL HETEROGENEITY; CHRONIC DISEASE; CONTROLLED STUDY; HEPATITIS B; HEPATITIS B VIRUS; IMMUNE RESPONSE; IN VIVO STUDY; LIVER CELL; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TRANSGENIC MOUSE;

EID: 0036227740     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(02)00305-9     Document Type: Article

References (41)

1. Diverse Cd1d-restricted T cells: Diverse phenotypes, and diverse functions
2. Increased interleukin 4 and immunoglobulin E production in transgenic mice overexpressing NK1 T cells
3. Mouse CD1-specific NK1 T cells: Development, specificity, and function
4. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers
5. Interleukin-12 inhibits hepatitis B virus replication in transgenic mice
6. NK1.1+ CD4+ T cells lose NK1.1 expression upon in vitro activation
7. Hepatitis B virus immunopathogenesis
8. A transgenic mouse model of the chronic hepatitis B surface antigen carrier state
9. Expression of hepatitis B virus large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic mice
10. Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice
11. The majority of H2-M3 is retained intracellularly in a peptide-receptive state and traffics to the cell surface in the presence of N-formylated peptides
12. IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells
13. Transient control of Interleukin-4-producing Natural Killer T cells in the livers of Listeria monocytogenes-infected mice by interleukin-12
14. Hepadnaviridae and their Replication
15. Tumor necrosis factor alpha negatively regulates hepatitis B virus gene expression in transgenic mice
16. HBsAg retention sensitizes the hepatocyte to injury by physiological concentrations of interferon-gamma
17. Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells
18. Cytokine-induced viral purging - Role in viral pathogenesis
19. High-level hepatitis B virus replication in transgenic mice
20. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes
21. Viral clearance without destruction of infected cells during acute HBV infection
22. Interleukin-2 downregulates hepatitis B virus gene expression in transgenic mice by a posttranscriptional mechanism
23. Selective loss of natural killer T cells by apoptosis following infection with Lymphocytic Choriomeningitis Virus
24. Natural killer T cell activation inhibits hepatitis B virus replication in vivo
25. Inhibition of hepatitis B virus replication by activation of NK T cells does not require inflammatory cell recruitment to the liver
26. Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis
27. Characterization of a monoclonal antibody which detects all murine alpha beta T cell receptors
28. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers
29. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4
30. Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages
31. RAG-1-deficient mice have no mature B and T lymphocytes
32. Monoclonal antibodies raised against engineered soluble mouse T cell receptors and specific for V alpha 8-, V beta 2- or V beta 10-bearing T cells
33. Characterization of a rat monoclonal antibody specific for a determinant encoded by the V beta 7 gene segment. Depletion of V beta 7+ T cells in mice with Mls-1a haplotype
34. Liver CD4-CD8_NK1.1+TCR αβ intermediate cells increase during experimental malaria infection and are able to exhibit inhibitory activity against the parasite liver stage in vitro
35. The CD1 system: Antigen-presenting molecules for T cell recognition of lipids and glycolipids
36. Characterization of a murine monoclonal antibody specific for an allotypic determinant on T cell antigen receptor
37. Posttranscriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte-activated hepatocytes
38. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors
39. Breaking tolerance leads to autoantibody production but not autoimmune liver disease in hepatitis B virus envelope transgenic mice
40. The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: The NK gene complex